U.S. Physical Therapy, Inc. (NYSE:USPH) Position Boosted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 426,298 shares of the company's stock after purchasing an additional 7,890 shares during the period. Dimensional Fund Advisors LP owned 2.82% of U.S. Physical Therapy worth $37,818,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in USPH. Wells Fargo & Company MN grew its position in U.S. Physical Therapy by 2.2% in the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after buying an additional 2,465 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of U.S. Physical Therapy by 37.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock valued at $409,000 after buying an additional 1,254 shares in the last quarter. Copeland Capital Management LLC grew its position in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock valued at $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in U.S. Physical Therapy during the fourth quarter worth $3,526,000. Finally, Bridge City Capital LLC increased its position in U.S. Physical Therapy by 7.0% during the 4th quarter. Bridge City Capital LLC now owns 64,947 shares of the company's stock worth $5,761,000 after purchasing an additional 4,235 shares in the last quarter.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

USPH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lowered their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Finally, StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Stock Up 0.3 %

NYSE:USPH traded up $0.19 on Thursday, reaching $71.15. The stock had a trading volume of 178,737 shares, compared to its average volume of 109,060. The company has a 50-day moving average of $72.41 and a 200 day moving average of $83.82. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $108.14. The stock has a market cap of $1.08 billion, a P/E ratio of 75.69, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.41 earnings per share for the quarter, missing analysts' consensus estimates of $0.46 by ($0.05). The business had revenue of $183.79 million for the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. U.S. Physical Therapy's quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.51 EPS. On average, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.53%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.